Compare CEPU & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CEPU | RAPP |
|---|---|---|
| Founded | 1989 | 2022 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2018 | 2024 |
| Metric | CEPU | RAPP |
|---|---|---|
| Price | $15.55 | $27.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $17.50 | ★ $47.00 |
| AVG Volume (30 Days) | ★ 350.1K | 316.8K |
| Earning Date | 03-10-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $607,552,200.00 | N/A |
| Revenue This Year | $16.07 | N/A |
| Revenue Next Year | $15.36 | N/A |
| P/E Ratio | $12.38 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.43 | $6.43 |
| 52 Week High | $18.50 | $42.27 |
| Indicator | CEPU | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 43.91 | 52.30 |
| Support Level | $15.18 | $26.57 |
| Resistance Level | $16.49 | $28.99 |
| Average True Range (ATR) | 0.79 | 1.84 |
| MACD | -0.10 | 0.21 |
| Stochastic Oscillator | 15.56 | 68.69 |
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.